These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19498105)

  • 21. Internalization and distribution of three alpha1-adrenoceptor subtypes in HEK293A cells before and after agonist stimulation.
    Wang SY; Song Y; Xu M; He QH; Han QD; Zhang YY
    Acta Pharmacol Sin; 2007 Mar; 28(3):359-66. PubMed ID: 17302998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vitro characterization of N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8- tetrahydronaphthalen-1-yl]methanesulfonamide and its enantiomers: a novel selective alpha 1A receptor agonist.
    Meyer MD; Altenbach RJ; Hancock AA; Buckner SA; Knepper SM; Kerwin JF
    J Med Chem; 1996 Sep; 39(20):4116-9. PubMed ID: 8831777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo pharmacodynamic interactions between two drugs used in orthostatic hypotension--midodrine and dihydroergotamine.
    Jourdan G; Verwaerde P; Pathak A; Tran MA; Montastruc JL; Senard JM
    Fundam Clin Pharmacol; 2007 Feb; 21(1):45-53. PubMed ID: 17227444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrine.
    Altenbach RJ; Khilevich A; Meyer MD; Buckner SA; Milicic I; Daza AV; Brune ME; O'Neill AB; Gauvin DM; Cain JC; Nakane M; Holladay MW; Williams M; Brioni JD; Sullivan JP
    J Med Chem; 2002 Sep; 45(20):4395-7. PubMed ID: 12238918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The translational pharmacology of a novel, potent, and selective nonsteroidal progesterone receptor antagonist, 2-[4-(4-cyano-phenoxy)-3,5-dicyclopropyl-1H-pyrazol-1-yl]-N-methylacetamide (PF-02367982).
    de Giorgio-Miller A; Bungay P; Tutt M; Owen J; Goodwin D; Pullen N
    J Pharmacol Exp Ther; 2008 Oct; 327(1):78-87. PubMed ID: 18593954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence.
    Brennan PE; Whitlock GA; Ho DK; Conlon K; McMurray G
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4999-5003. PubMed ID: 19646865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of tamsulosin on resting urethral pressure and arterial blood pressure in anaesthetized female dogs.
    Ohtake A; Sato S; Sasamata M; Miyata K
    J Pharm Pharmacol; 2006 Mar; 58(3):345-50. PubMed ID: 16536901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation on human skin fibroblast by alpha1 adrenergic receptor subtypes.
    Sterin-Borda L; Furlan C; Orman B; Borda E
    Biochem Pharmacol; 2007 Nov; 74(9):1401-12. PubMed ID: 17714696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of cAMP accumulation mediated by three alpha1-adrenoceptor subtypes in HEK293 cells.
    Song Y; Huang Y; Dong ED; Han QD; Zhang YY
    Acta Pharmacol Sin; 2003 Jun; 24(6):549-54. PubMed ID: 12791181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).
    Pallavicini M; Budriesi R; Fumagalli L; Ioan P; Chiarini A; Bolchi C; Ugenti MP; Colleoni S; Gobbi M; Valoti E
    J Med Chem; 2006 Nov; 49(24):7140-9. PubMed ID: 17125266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tasipimidine-the pharmacological profile of a novel orally active selective α
    Lehtimäki J; Jalava N; Unkila K; Aspegren J; Haapalinna A; Pesonen U
    Eur J Pharmacol; 2022 May; 923():174949. PubMed ID: 35405115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of bladder outlet obstruction on alpha1- and beta-adrenoceptor expression and function.
    Barendrecht MM; Frazier EP; Vrydag W; Alewijnse AE; Peters SL; Michel MC
    Neurourol Urodyn; 2009; 28(4):349-55. PubMed ID: 19034955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of 2-[(5-methylbenz-1-ox-4-azin-6-yl)imino]imidazoline, a potent, peripherally acting alpha 2 adrenoceptor agonist.
    Munk SA; Harcourt D; Ambrus G; Denys L; Gluchowski C; Burke JA; Kharlamb AB; Manlapaz CA; Padillo EU; Runde E; Williams L; Wheeler LA; Garst ME
    J Med Chem; 1996 Aug; 39(18):3533-8. PubMed ID: 8784451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioisosteric phentolamine analogs as selective human alpha(2)- versus alpha(1)-adrenoceptor ligands.
    Bavadekar SA; Hong SS; Lee SI; Miller DD; Feller DR
    Eur J Pharmacol; 2008 Aug; 590(1-3):53-60. PubMed ID: 18589415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT(2C) agonists.
    Andrews MD; Green MP; Allerton CM; Batchelor DV; Blagg J; Brown AD; Gordon DW; McMurray G; Millns DJ; Nichols CL; Watson L
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5346-50. PubMed ID: 19692241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized crossover study to evaluate Ro 115-1240, a selective alpha-adrenoceptor partial agonist in women with stress urinary incontinence.
    Wein AJ
    BJU Int; 2004 May; 93(7):1115. PubMed ID: 15142177
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacological properties of 2-[(5-chloro-2-methoxyphenyl)azo]-1H-imidazole (M6434).
    Ohnishi H; Yamaguchi K; Satoh M; Obata M; Uemura A; Toyonaka Y; Suzuki Y
    Arzneimittelforschung; 1981; 31(9):1425-9. PubMed ID: 7197948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats.
    El-Mas MM; Omar AG; Helmy MM; Mohy El-Din MM
    Brain Res; 2009 Jan; 1248():96-106. PubMed ID: 19028461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.
    Giardinà D; Martarelli D; Sagratini G; Angeli P; Ballinari D; Gulini U; Melchiorre C; Poggesi E; Pompei P
    J Med Chem; 2009 Aug; 52(15):4951-4. PubMed ID: 19719240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system.
    Andersson KE; Gratzke C
    Nat Clin Pract Urol; 2007 Jul; 4(7):368-78. PubMed ID: 17615548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.